From the Boston Globe Business Team
FDA clears two new Boston Scientific defibrillators
Email|
Text size
–
+
May 13, 2008 06:15 PM
The medical device maker Boston Scientific Co. today said that the Food and Drug Administration has approved two of its new heart devices.
The FDA approved the Cognis defibrillator and the Teligen implantable defibrillator, both of which are used to treat heart failure.
Shares of Natick-based Boston Scientific rose 20 cents to $13.21 in after-hours electronic trading, from their close at $13.01 during the regular session.
(AP)
